TY  - GEN
AU  - Riedl,Marc A
AU  - Levy,Robyn J
AU  - Suez,Daniel
AU  - Lockey,Richard F
AU  - Baker,James W
AU  - Relan,Anurag
AU  - Zuraw,Bruce L
TI  - Efficacy and safety of recombinant C1 inhibitor for the treatment of hereditary angioedema attacks: a North American open-label study
SN  - 1534-4436
PY  - 2013///0523
KW  - Adolescent
KW  - Adult
KW  - Angioedemas, Hereditary
KW  - drug therapy
KW  - Complement C1 Inhibitor Protein
KW  - administration & dosage
KW  - Double-Blind Method
KW  - Female
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - North America
KW  - Recombinant Proteins
KW  - Treatment Outcome
KW  - Young Adult
N1  - Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.anai.2013.02.007
ER  -